Low Positive Predictive Value of the Oral Brush Biopsy in Detecting Dysplastic Oral Lesions

被引:24
作者
Bhoopathi, Vinodh [1 ]
Kabani, Sadru [2 ]
Mascarenhas, Ana Karina [1 ]
机构
[1] Boston Univ, Sch Dent Med, Div Dent Publ Hlth, Boston, MA 02117 USA
[2] Boston Univ, Sch Dent Med, Oral & Maxillofacial Pathol Dept, Boston, MA 02215 USA
关键词
OralCDx brush biopsy; dysplastic oral lesions; positive predictive values; false-positive cases; FALSE POSITIVES; CANCER; SPECIFICITY; SENSITIVITY;
D O I
10.1002/cncr.24089
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The authors evaluated the effectiveness of the oral brush biopsy technique as a diagnostic tool in detecting dysplastic oral lesions. METHODS: In this cross-sectional study, pathologic reports (n=152) from the scalpel biopsies (tissue samples) in patients who previously tested either "positive" (n=3) or "atypical" (n=149) for dysplasia by brush biopsy (OralCDX) were evaluated. Information on the age and sex of the patient, the site of the lesion, the brush biopsy results, and the histopathologic diagnosis of the scalpel biopsy was collected. The positive predictive values (PPVs) for "abnormal," "atypical," and "positive" brush biopsies were determined. RESULTS: Overall, the PPV of an abnormal brush biopsy was only 7.9% (95% confidence interval [CI], 4.2%-13.4%), and the PPV of an "atypical" brush biopsy was 7.4% (95% CI, 3.7%-12.8%). Of the 3 positive brush biopsies, only 1 was identified as dysplastic. The proportion of false-positive biopsy results was as high as 92.1% (95% CI, 86.6%-95.9%). CONCLUSIONS: The OralCDx technique overestimated dysplastic lesions and produced a high number of false-positive results. Cancer 2009;115:1036-40. (c) 2009 American Cancer Society.
引用
收藏
页码:1036 / 1040
页数:5
相关论文
共 19 条
[1]  
Acha Amelia, 2005, Med Oral Patol Oral Cir Bucal, V10, P95
[2]  
*AM CANC SOC, CANC FACTS FIG 2002
[3]  
*AM CANC SOC, CANC FACTS FIG 2006
[4]  
[Anonymous], SEER Cancer Statistics Review 1975-2008
[5]  
[Anonymous], COCHRANE DATABASE SY
[6]   Prognostic and predictive factors in oral squamous cell cancer:: important tools for planning individual therapy? [J].
Bettendorf, O ;
Piffkò, J ;
Bànkfalvi, A .
ORAL ONCOLOGY, 2004, 40 (02) :110-119
[7]   REFERRAL DELAY IN DIAGNOSIS OF ORO/OROPHARYNGEAL CANCER IN ISRAEL [J].
GORSKY, M ;
DAYAN, D .
ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1995, 31B (03) :166-168
[8]   Screening for familial ovarian cancer: The need for well-designed prospective studies [J].
Jacobs, I .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5443-5445
[9]   ANATOMIC ORIGINS AND LOCATIONS OF ORAL CANCER [J].
MOORE, C ;
CATLIN, D .
AMERICAN JOURNAL OF SURGERY, 1967, 114 (04) :510-&
[10]  
*ORALCDX LAB, PREV BEST MED